Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Curr Med Sci ; 43(6): 1061-1065, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37924387

RESUMO

Long COVID symptoms typically occur within 3 months of an initial COVID-19 infection, last for more than 2 months, and cannot be explained by other diagnoses. The most common symptoms include fatigue, dyspnea, coughing, and cognitive impairment. The mechanisms of long COVID are not fully understood, but several hypotheses have been put forth. These include coagulation and fibrosis pathway activation, inflammatory and autoimmune manifestations, persistent virus presence, and Epstein-Barr virus reactivation. Hyperbaric oxygen therapy (HBOT) is a therapeutic method in which a person inhales 100% oxygen under pressure greater than that of the atmosphere. HBOT has some therapeutic effects, including improvement of microcirculation, inhibition of cytokine release leading to a reduction in inflammatory responses, inhibition of autoimmune responses, and promotion of neurological repair. Several clinical trials have been carried out using HBOT to treat long COVID. The results suggest that HBOT helps to improve symptom severity, reduce symptom duration, and enhance patients' quality of life. It is believed that HBOT is an effective option for patients with long COVID, which is worth actively promoting.


Assuntos
COVID-19 , Infecções por Vírus Epstein-Barr , Oxigenoterapia Hiperbárica , Humanos , Oxigenoterapia Hiperbárica/métodos , Oxigênio , Síndrome de COVID-19 Pós-Aguda , Qualidade de Vida , COVID-19/terapia , Herpesvirus Humano 4
2.
Brain Topogr ; 24(2): 127-33, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21499934

RESUMO

Sensory gating, a viable function of the brain, is an adaptive mechanism to prevent overstimulation of nervous system. The aim of this study was to examine the effect of homobaric pure (i.e. 100%) oxygen on the human brain at different periods of inhalation. EEG was recorded while an auditory paired-click sensory gating test was conducted during 4 study periods: before inhalation of pure oxygen (Before), inhalation of 100% oxygen (air in control group) for 20 min (Oxy20) and 50 min (Oxy50), 30 min after oxygen (air in control group) inhalation (After). Each of the auditory stimuli elicited 4 clear peaks at 20, 39, 55 and 100 ms in ERPs, demonstrating that sensory gating is a multi-stage process. Comparing the S1-S2 differences of field potentials between two groups, significant experimental effects (P < 0.05-0.01) were shown at Oxy50 and After periods mainly at the 20 and 100 ms peak in ERPs. Pure oxygen was experimentally shown, for the first time, to affect the human brain activation, at the beginning of early P20 sensory cortical activation and late N100 auditory perception. The effect found in this study shall encourage further investigation on the oxygen treatment in human brain.


Assuntos
Percepção Auditiva/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Encéfalo/fisiologia , Potenciais Evocados/efeitos dos fármacos , Oxigênio/administração & dosagem , Filtro Sensorial/efeitos dos fármacos , Estimulação Acústica/métodos , Adulto , Pressão do Ar , Percepção Auditiva/fisiologia , Mapeamento Encefálico/métodos , Eletroencefalografia/efeitos dos fármacos , Potenciais Evocados/fisiologia , Humanos , Masculino , Oxigênio/fisiologia , Consumo de Oxigênio/fisiologia , Tempo de Reação/efeitos dos fármacos , Tempo de Reação/fisiologia , Filtro Sensorial/fisiologia , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA